Steven R Smith, MD | |
900 Seton Dr, Cumberland, MD 21502-1854 | |
(301) 723-1443 | |
(301) 723-1480 |
Full Name | Steven R Smith |
---|---|
Gender | Male |
Speciality | Pulmonary Disease |
Experience | 52 Years |
Location | 900 Seton Dr, Cumberland, Maryland |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1205812013 | NPI | - | NPPES |
BLUE CHOICE | Other | DC | J697 001 |
P00135060 | Other | MD | TRAVELERS MEDICARE |
1840787000 | Medicaid | WV | |
615935 01 | Other | MD | CAREFIRST BC BS |
718200700 | Medicaid | MD | |
615935 02 | Other | MD | CAREFIRST BC BS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RP1001X | Internal Medicine - Pulmonary Disease | D18216 (Maryland) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Western Maryland Regional Medical Center | Cumberland, MD | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Upmc Western Maryland Health Services Llc | 7113396011 | 151 |
News Archive
E'shee Skin Care products are the result of a careful collaboration of skin care professionals, doctors and chemists; these revolutionary new products are the next step in skin care.
The first patient in a cellular immunotherapy Phase 1 cancer trial at Seattle Children's has had a positive response to T-cell therapy. The 23-year-old patient, Lynsie Conradi, from Bellingham, Wash. received the welcome news yesterday.
AbbVie, a global biopharmaceutical company, today announced findings from a Phase 2 study of the investigational medicine veliparib combined with the chemotherapy regimen carboplatin and paclitaxel that showed an improvement in median progression-free survival (PFS) in patients with previously untreated metastatic or advanced non-small cell lung cancer (NSCLC) who are current smokers.
Fresenius Medical Care, the world's leading provider of dialysis products and services, announced the further enhancement of support for home dialysis patients in Western Australia.
› Verified 3 days ago
Entity Name | Upmc Western Maryland Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1184769952 PECOS PAC ID: 7113900655 Enrollment ID: O20040608000157 |
News Archive
E'shee Skin Care products are the result of a careful collaboration of skin care professionals, doctors and chemists; these revolutionary new products are the next step in skin care.
The first patient in a cellular immunotherapy Phase 1 cancer trial at Seattle Children's has had a positive response to T-cell therapy. The 23-year-old patient, Lynsie Conradi, from Bellingham, Wash. received the welcome news yesterday.
AbbVie, a global biopharmaceutical company, today announced findings from a Phase 2 study of the investigational medicine veliparib combined with the chemotherapy regimen carboplatin and paclitaxel that showed an improvement in median progression-free survival (PFS) in patients with previously untreated metastatic or advanced non-small cell lung cancer (NSCLC) who are current smokers.
Fresenius Medical Care, the world's leading provider of dialysis products and services, announced the further enhancement of support for home dialysis patients in Western Australia.
› Verified 3 days ago
Entity Name | Upmc Western Maryland Health Services Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1447976584 PECOS PAC ID: 7113396011 Enrollment ID: O20221216000041 |
News Archive
E'shee Skin Care products are the result of a careful collaboration of skin care professionals, doctors and chemists; these revolutionary new products are the next step in skin care.
The first patient in a cellular immunotherapy Phase 1 cancer trial at Seattle Children's has had a positive response to T-cell therapy. The 23-year-old patient, Lynsie Conradi, from Bellingham, Wash. received the welcome news yesterday.
AbbVie, a global biopharmaceutical company, today announced findings from a Phase 2 study of the investigational medicine veliparib combined with the chemotherapy regimen carboplatin and paclitaxel that showed an improvement in median progression-free survival (PFS) in patients with previously untreated metastatic or advanced non-small cell lung cancer (NSCLC) who are current smokers.
Fresenius Medical Care, the world's leading provider of dialysis products and services, announced the further enhancement of support for home dialysis patients in Western Australia.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Steven R Smith, MD Po Box 1671, Cumberland, MD 21501-1671 Ph: (240) 964-8342 | Steven R Smith, MD 900 Seton Dr, Cumberland, MD 21502-1854 Ph: (301) 723-1443 |
News Archive
E'shee Skin Care products are the result of a careful collaboration of skin care professionals, doctors and chemists; these revolutionary new products are the next step in skin care.
The first patient in a cellular immunotherapy Phase 1 cancer trial at Seattle Children's has had a positive response to T-cell therapy. The 23-year-old patient, Lynsie Conradi, from Bellingham, Wash. received the welcome news yesterday.
AbbVie, a global biopharmaceutical company, today announced findings from a Phase 2 study of the investigational medicine veliparib combined with the chemotherapy regimen carboplatin and paclitaxel that showed an improvement in median progression-free survival (PFS) in patients with previously untreated metastatic or advanced non-small cell lung cancer (NSCLC) who are current smokers.
Fresenius Medical Care, the world's leading provider of dialysis products and services, announced the further enhancement of support for home dialysis patients in Western Australia.
› Verified 3 days ago
Dr. Feiyu Hong, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 12500 Willowbrook Rd, Cumberland, MD 21502 Phone: 240-964-7000 | |
Dr. Robustiano Jocson Barrera Jr., M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 200 Glenn Street, Suite #302, Cumberland, MD 21502 Phone: 240-522-0470 Fax: 240-522-0471 | |
Dr. James B. Deren, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1050 W Industrial Blvd, Cumberland, MD 21502 Phone: 240-964-9355 Fax: 240-964-9356 | |
Dr. Christopher Haas, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 12502 Willowbrook Rd, Suite 330, Cumberland, MD 21502 Phone: 240-964-8740 | |
Sunil Kumar Gupta, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 625 Kent Ave Ste 101, Cumberland, MD 21502 Phone: 301-724-7117 | |
Dr. Qamar Ul Zaman, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 12502 Willowbrook Rd, Suite 440, Cumberland, MD 21502 Phone: 301-777-3111 Fax: 301-777-0963 | |
Dr. Gregg C Donaldson, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 912 Seton Dr, Cumberland, MD 21502 Phone: 301-722-3111 Fax: 301-722-5135 |